532 related articles for article (PubMed ID: 17445902)
21. Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery.
Maca SM; Amon M; Findl O; Kahraman G; Barisani-Asenbauer T
Am J Ophthalmol; 2010 May; 149(5):777-84. PubMed ID: 20152959
[TBL] [Abstract][Full Text] [Related]
22. Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome.
Coassin M; Iovieno A; Soldani A; Cavuto S; Cimino L; Sartori A; Formisano D; Fontana L
J Cataract Refract Surg; 2016 Aug; 42(8):1119-25. PubMed ID: 27531286
[TBL] [Abstract][Full Text] [Related]
23. Comparison of topically applied flurbiprofen or bromfenac ophthalmic solution on post-operative ocular hypertension in canine patients following cataract surgery.
Lu J; English R; Nadelstein B; Weigt A; Berdoulay A; Binder D; Ngan E
Vet Ophthalmol; 2017 Mar; 20(2):107-113. PubMed ID: 26990912
[TBL] [Abstract][Full Text] [Related]
24. Acute corneal melt associated with topical bromfenac use.
Prasher P
Eye Contact Lens; 2012 Jul; 38(4):260-2. PubMed ID: 22169877
[TBL] [Abstract][Full Text] [Related]
25. Phase II results of an intraocular steroid delivery system for cataract surgery.
Chang DF; Garcia IH; Hunkeler JD; Minas T
Ophthalmology; 1999 Jun; 106(6):1172-7. PubMed ID: 10366088
[TBL] [Abstract][Full Text] [Related]
26. Comparison of ketorolac 0.4% and bromfenac 0.09% at trough dosing: aqueous drug absorption and prostaglandin E2 levels.
Bucci FA; Waterbury LD
J Cataract Refract Surg; 2008 Sep; 34(9):1509-12. PubMed ID: 18721711
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation.
Sandoval HP; De Castro LE; Vroman DT; Solomon KD
J Ocul Pharmacol Ther; 2006 Aug; 22(4):251-7. PubMed ID: 16910866
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of bromfenac for the treatment of corneal ulcer pain.
Schechter BA; Trattler W
Adv Ther; 2010 Oct; 27(10):756-61. PubMed ID: 20845001
[TBL] [Abstract][Full Text] [Related]
29. Nepafenac dosing frequency for ocular pain and inflammation associated with cataract surgery.
Maxwell WA; Reiser HJ; Stewart RH; Cavanagh HD; Walters TR; Sager DP; Meuse PA
J Ocul Pharmacol Ther; 2008 Dec; 24(6):593-9. PubMed ID: 19040348
[TBL] [Abstract][Full Text] [Related]
30. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
Schwab IR; Friedlaender M; McCulley J; Lichtenstein SJ; Moran CT;
Ophthalmology; 2003 Mar; 110(3):457-65. PubMed ID: 12623805
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of bromfenac and ibuprofen for pain after orthopedic surgery.
Boström AA; Forbes JA; Adolfsson C; Beaver WT; Bell WE
Pharmacotherapy; 1994; 14(3):305-13. PubMed ID: 7937271
[TBL] [Abstract][Full Text] [Related]
32. A phase III, multicenter, randomized, placebo-controlled clinical trial of topical aminocaproic acid (Caprogel) in the management of traumatic hyphema.
Pieramici DJ; Goldberg MF; Melia M; Fekrat S; Bradford CA; Faulkner A; Juzych M; Parker JS; McLeod SD; Rosen R; Santander SH
Ophthalmology; 2003 Nov; 110(11):2106-12. PubMed ID: 14597516
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of clinical effects of bromfenac sodium ophthalmic solution 0.1% versus glucocorticoids for post-LASEK usage].
Chen S; Jiang Y; Yu C; Li Y
Zhonghua Yan Ke Za Zhi; 2015 Jan; 51(1):45-50. PubMed ID: 25877710
[TBL] [Abstract][Full Text] [Related]
34. Topical bromfenac 0.09% vs. ketorolac 0.4% for the control of pain, photophobia, and discomfort following PRK.
Sher NA; Golben MR; Bond W; Trattler WB; Tauber S; Voirin TG
J Refract Surg; 2009 Feb; 25(2):214-20. PubMed ID: 19241773
[TBL] [Abstract][Full Text] [Related]
35. One-year multicenter, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia.
Tan DT; Lam DS; Chua WH; Shu-Ping DF; Crockett RS;
Ophthalmology; 2005 Jan; 112(1):84-91. PubMed ID: 15629825
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of loteprednol etabonate 0.5% gel in the treatment of ocular inflammation and pain after cataract surgery.
Rajpal RK; Roel L; Siou-Mermet R; Erb T
J Cataract Refract Surg; 2013 Feb; 39(2):158-67. PubMed ID: 23218817
[TBL] [Abstract][Full Text] [Related]
37. Global experience with Xibrom (bromfenac ophthalmic solution) 0.09%: the first twice-daily ophthalmic nonsteroidal anti-inflammatory drug.
Donnenfeld ED; Donnenfeld A
Int Ophthalmol Clin; 2006; 46(4):21-40. PubMed ID: 17060789
[No Abstract] [Full Text] [Related]
38. Comparison of tilidine/naloxone, tramadol and bromfenac in experimental pain: a double-blind randomized crossover study in healthy human volunteers.
Högger P; Rohdewald P
Int J Clin Pharmacol Ther; 1999 Aug; 37(8):377-85. PubMed ID: 10475140
[TBL] [Abstract][Full Text] [Related]
39. Comparison of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis.
Miyake-Kashima M; Takano Y; Tanaka M; Satake Y; Kawakita T; Dogru M; Asano-Kato N; Fukagawa K; Fujishima H
Jpn J Ophthalmol; 2004; 48(6):587-90. PubMed ID: 15592786
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of ophthalmic nonsteroidal antiinflammatory drugs in suppressing anterior capsule contraction and secondary posterior capsule opacification.
Mukai K; Matsushima H; Gotoh N; Aose M; Satoshi W; Wataru T; Matsui E; Nagata M; Senoo T
J Cataract Refract Surg; 2009 Sep; 35(9):1614-8. PubMed ID: 19683162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
